- Home
- HOUR vs BMEA Comparison
HOUR vs BMEA Comparison
Compare HOUR & BMEA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HOUR
- BMEA
- Stock Information
- Founded
- HOUR 2015
- BMEA 2017
- Country
- HOUR United States
- BMEA United States
- Employees
- HOUR N/A
- BMEA N/A
- Industry
- HOUR Catalog/Specialty Distribution
- BMEA Biotechnology: Pharmaceutical Preparations
- Sector
- HOUR Consumer Discretionary
- BMEA Health Care
- Exchange
- HOUR Nasdaq
- BMEA Nasdaq
- Market Cap
- HOUR 125.8M
- BMEA 145.0M
- IPO Year
- HOUR 2022
- BMEA 2021
- Fundamental
- Price
- HOUR $2.19
- BMEA $3.98
- Analyst Decision
- HOUR
- BMEA Buy
- Analyst Count
- HOUR 0
- BMEA 13
- Target Price
- HOUR N/A
- BMEA $27.92
- AVG Volume (30 Days)
- HOUR 5.3M
- BMEA 939.5K
- Earning Date
- HOUR 11-12-2024
- BMEA 10-29-2024
- Dividend Yield
- HOUR N/A
- BMEA N/A
- EPS Growth
- HOUR N/A
- BMEA N/A
- EPS
- HOUR 0.05
- BMEA N/A
- Revenue
- HOUR $143,314,112.00
- BMEA N/A
- Revenue This Year
- HOUR $39.97
- BMEA N/A
- Revenue Next Year
- HOUR N/A
- BMEA N/A
- P/E Ratio
- HOUR $43.32
- BMEA N/A
- Revenue Growth
- HOUR 15.71
- BMEA N/A
- 52 Week Low
- HOUR $0.83
- BMEA $3.61
- 52 Week High
- HOUR $6.90
- BMEA $20.21
- Technical
- Relative Strength Index (RSI)
- HOUR 51.04
- BMEA 35.19
- Support Level
- HOUR $2.15
- BMEA $3.78
- Resistance Level
- HOUR $2.56
- BMEA $4.29
- Average True Range (ATR)
- HOUR 0.35
- BMEA 0.29
- MACD
- HOUR -0.06
- BMEA 0.14
- Stochastic Oscillator
- HOUR 9.71
- BMEA 49.26
About HOUR Hour Loop Inc.
Hour Loop Inc is a technology-enabled consumer products company that uses machine learning and data analytics to design, develop, market, and sell products. Hour Loop predominantly operates through online retail channels such as Amazon, Walmart, and Hourloop.com. The Company, as an Internet marketplace seller, sells products in multiple categories, including home/garden decor, toys, kitchenware, apparel, and electronics. It has only one segment, which is online retail (e-commerce).
About BMEA Biomea Fusion Inc.
Biomea Fusion Inc is a preclinical-stage biopharmaceutical company. It is focused on the discovery, development and commercialization of irreversible small molecule drugs to treat patients with genetically defined cancers. The company's product candidate, BMF-219, is designed to be an orally bioavailable, potent and selective irreversible inhibitor of menin, an important transcriptional regulator known to play a direct role in oncogenic signaling in multiple cancers.